Research Summary
RNA interference (RNAi) for therapeutic purposes involves harnessing the natural biological process of RNAi to selectively and precisely regulate gene expression within cells. RNAi is a mechanism where small RNA molecules, such as small interfering RNA (siRNA) or microRNA (miRNA), interfere with the translation or stability of specific messenger RNA (mRNA) molecules, thereby preventing the synthesis of a particular protein. In therapeutic applications, researchers design and deliver synthetic RNA molecules to target and silence disease-associated genes, offering a potential strategy for treating various genetic disorders, viral infections, and certain cancers. RNAi therapeutics aim to exploit this precise gene-silencing mechanism to intervene at the molecular level and correct or mitigate the underlying causes of diseases. While challenges such as effective delivery and off-target effects need to be addressed, RNAi holds significant promise as a novel and targeted approach in the field of personalized medicine and therapeutic development.
According to DIResearch's in-depth investigation and research, the global RNAi for Therapeutic market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.
The major global manufacturers of RNAi for Therapeutic include Alnylam Pharmaceuticals, Arbutus Biopharma (Tekmira), Arrowhead, Dicerna Pharmaceuticals, Mirna Therapeutics, Quark Pharmaceuticals, RXi Pharmaceuticals, Benitec Biopharma, Silence Therapeutics, Sylentis, miRagen Therapeutics, Gradalis, Sirnaomics, Silenseed etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of RNAi for Therapeutic. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global RNAi for Therapeutic market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the RNAi for Therapeutic market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of RNAi for Therapeutic industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of RNAi for Therapeutic Include:
Alnylam Pharmaceuticals
Arbutus Biopharma (Tekmira)
Arrowhead
Dicerna Pharmaceuticals
Mirna Therapeutics
Quark Pharmaceuticals
RXi Pharmaceuticals
Benitec Biopharma
Silence Therapeutics
Sylentis
miRagen Therapeutics
Gradalis
Sirnaomics
Silenseed
RNAi for Therapeutic Product Segment Include:
siRNA
miRNA
shRNA
RNAi for Therapeutic Product Application Include:
Cancer
Cardiovascular
HBV
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global RNAi for Therapeutic Industry PESTEL Analysis
Chapter 3: Global RNAi for Therapeutic Industry Porter's Five Forces Analysis
Chapter 4: Global RNAi for Therapeutic Major Regional Market Size and Forecast Analysis
Chapter 5: Global RNAi for Therapeutic Market Size and Forecast by Type and Application Analysis
Chapter 6: North America RNAi for Therapeutic Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe RNAi for Therapeutic Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China RNAi for Therapeutic Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) RNAi for Therapeutic Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America RNAi for Therapeutic Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa RNAi for Therapeutic Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global RNAi for Therapeutic Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents 1 RNAi for Therapeutic Market Overview 1.1 Product Definition and Statistical Scope 1.2 RNAi for Therapeutic Product by Type 1.2.1 Global RNAi for Therapeutic Market Size by Type, 2023 VS 2024 VS 2030 1.2.2 siRNA 1.2.3 miRNA 1.2.4 shRNA 1.3 RNAi for Therapeutic Product by Application 1.3.1 Global RNAi for Therapeutic Market Size by Application, 2023 VS 2024 VS 2030 1.3.2 Cancer 1.3.3 Cardiovascular 1.3.4 HBV 1.3.5 Others 1.4 Global RNAi for Therapeutic Market Revenue Analysis (2019-2030) 1.5 RNAi for Therapeutic Market Development Status and Trends 1.5.1 RNAi for Therapeutic Industry Development Status Analysis 1.5.2 RNAi for Therapeutic Industry Development Trends Analysis 2 RNAi for Therapeutic Market PESTEL Analysis 2.1 Political Factors Analysis 2.2 Economic Factors Analysis 2.3 Social Factors Analysis 2.4 Technological Factors Analysis 2.5 Environmental Factors Analysis 2.6 Legal Factors Analysis 3 RNAi for Therapeutic Market Porter's Five Forces Analysis 3.1 Competitive Rivalry 3.2 Threat of New Entrants 3.3 Bargaining Power of Suppliers 3.4 Bargaining Power of Buyers 3.5 Threat of Substitutes 4 Global RNAi for Therapeutic Market Analysis by Regions 4.1 RNAi for Therapeutic Overall Market: 2023 VS 2024 VS 2030 4.2 Global RNAi for Therapeutic Revenue and Forecast Analysis (2019-2030) 4.2.1 Global RNAi for Therapeutic Revenue and Market Share by Region (2019-2024) 4.2.2 Global RNAi for Therapeutic Revenue Forecast by Region (2025-2030) 5 Global RNAi for Therapeutic Market Size by Type and Application 5.1 Global RNAi for Therapeutic Market Size by Type 5.2 Global RNAi for Therapeutic Market Size by Application 6 North America 6.1 North America RNAi for Therapeutic Market Size and Growth Rate Analysis (2019-2030) 6.2 North America Key Manufacturers Analysis 6.3 North America RNAi for Therapeutic Market Size by Type 6.4 North America RNAi for Therapeutic Market Size by Application 6.5 North America RNAi for Therapeutic Market Size by Country 6.5.1 US 6.5.2 Canada 7 Europe 7.1 Europe RNAi for Therapeutic Market Size and Growth Rate Analysis (2019-2030) 7.2 Europe Key Manufacturers Analysis 7.3 Europe RNAi for Therapeutic Market Size by Type 7.4 Europe RNAi for Therapeutic Market Size by Application 7.5 Europe RNAi for Therapeutic Market Size by Country 7.5.1 Germany 7.5.2 France 7.5.3 United Kingdom 7.5.4 Italy 7.5.5 Spain 7.5.6 Benelux 8 China 8.1 China RNAi for Therapeutic Market Size and Growth Rate Analysis (2019-2030) 8.2 China Key Manufacturers Analysis 8.3 China RNAi for Therapeutic Market Size by Type 8.4 China RNAi for Therapeutic Market Size by Application 9 APAC (excl. China) 9.1 APAC (excl. China) RNAi for Therapeutic Market Size and Growth Rate Analysis (2019-2030) 9.2 APAC (excl. China) Key Manufacturers Analysis 9.3 APAC (excl. China) RNAi for Therapeutic Market Size by Type 9.4 APAC (excl. China) RNAi for Therapeutic Market Size by Application 9.5 APAC (excl. China) RNAi for Therapeutic Market Size by Country 9.5.1 Japan 9.5.2 South Korea 9.5.3 India 9.5.4 Australia 9.5.5 Indonesia 9.5.6 Vietnam 9.5.7 Malaysia 9.5.8 Thailand 10 Latin America 10.1 Latin America RNAi for Therapeutic Market Size and Growth Rate Analysis (2019-2030) 10.2 Latin America Key Manufacturers Analysis 10.3 Latin America RNAi for Therapeutic Market Size by Type 10.4 Latin America RNAi for Therapeutic Market Size by Application 10.5 Latin America RNAi for Therapeutic Market Size by Country 10.5.1 Mecixo 10.5.2 Brazil 11 Middle East & Africa 11.1 Middle East & Africa RNAi for Therapeutic Market Size and Growth Rate Analysis (2019-2030) 11.2 Middle East & Africa Key Manufacturers Analysis 11.3 Middle East & Africa RNAi for Therapeutic Market Size by Type 11.4 Middle East & Africa RNAi for Therapeutic Market Size by Application 11.5 Middle East & Africa RNAi for Therapeutic Market Size by Country 11.5.1 Saudi Arabia 11.5.2 South Africa 12 Market Competition by Manufacturers 12.1 Global RNAi for Therapeutic Market Revenue by Key Manufacturers (2020-2024) 12.2 RNAi for Therapeutic Competitive Landscape Analysis and Market Dynamic 12.2.1 RNAi for Therapeutic Competitive Landscape Analysis 12.2.2 Global Key Manufacturers Headquarter and Key Area Sales 12.2.3 Market Dynamic 13 Key Companies Analysis 13.1 Alnylam Pharmaceuticals 13.1.1 Alnylam Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.1.2 Alnylam Pharmaceuticals RNAi for Therapeutic Product Portfolio 13.1.3 Alnylam Pharmaceuticals RNAi for Therapeutic Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.2 Arbutus Biopharma (Tekmira) 13.2.1 Arbutus Biopharma (Tekmira) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.2.2 Arbutus Biopharma (Tekmira) RNAi for Therapeutic Product Portfolio 13.2.3 Arbutus Biopharma (Tekmira) RNAi for Therapeutic Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.3 Arrowhead 13.3.1 Arrowhead Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.3.2 Arrowhead RNAi for Therapeutic Product Portfolio 13.3.3 Arrowhead RNAi for Therapeutic Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.4 Dicerna Pharmaceuticals 13.4.1 Dicerna Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.4.2 Dicerna Pharmaceuticals RNAi for Therapeutic Product Portfolio 13.4.3 Dicerna Pharmaceuticals RNAi for Therapeutic Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.5 Mirna Therapeutics 13.5.1 Mirna Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.5.2 Mirna Therapeutics RNAi for Therapeutic Product Portfolio 13.5.3 Mirna Therapeutics RNAi for Therapeutic Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.6 Quark Pharmaceuticals 13.6.1 Quark Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.6.2 Quark Pharmaceuticals RNAi for Therapeutic Product Portfolio 13.6.3 Quark Pharmaceuticals RNAi for Therapeutic Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.7 RXi Pharmaceuticals 13.7.1 RXi Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.7.2 RXi Pharmaceuticals RNAi for Therapeutic Product Portfolio 13.7.3 RXi Pharmaceuticals RNAi for Therapeutic Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.8 Benitec Biopharma 13.8.1 Benitec Biopharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.8.2 Benitec Biopharma RNAi for Therapeutic Product Portfolio 13.8.3 Benitec Biopharma RNAi for Therapeutic Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.9 Silence Therapeutics 13.9.1 Silence Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.9.2 Silence Therapeutics RNAi for Therapeutic Product Portfolio 13.9.3 Silence Therapeutics RNAi for Therapeutic Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.10 Sylentis 13.10.1 Sylentis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.10.2 Sylentis RNAi for Therapeutic Product Portfolio 13.10.3 Sylentis RNAi for Therapeutic Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.11 miRagen Therapeutics 13.11.1 miRagen Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.11.2 miRagen Therapeutics RNAi for Therapeutic Product Portfolio 13.11.3 miRagen Therapeutics RNAi for Therapeutic Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.12 Gradalis 13.12.1 Gradalis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.12.2 Gradalis RNAi for Therapeutic Product Portfolio 13.12.3 Gradalis RNAi for Therapeutic Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.13 Sirnaomics 13.13.1 Sirnaomics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.13.2 Sirnaomics RNAi for Therapeutic Product Portfolio 13.13.3 Sirnaomics RNAi for Therapeutic Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.14 Silenseed 13.14.1 Silenseed Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.14.2 Silenseed RNAi for Therapeutic Product Portfolio 13.14.3 Silenseed RNAi for Therapeutic Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 14 Industry Chain Analysis 14.1 RNAi for Therapeutic Industry Chain Analysis 14.2 RNAi for Therapeutic Industry Raw Material and Suppliers Analysis 14.2.1 Upstream Key Raw Material Supply Analysis 14.2.2 Raw Material Suppliers and Contact Information 14.3 RNAi for Therapeutic Typical Downstream Customers 14.4 RNAi for Therapeutic Sales Channel Analysis 15 Research Findings and Conclusion 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.2 Research Scope 16.3 Benchmarks and Assumptions 16.4 Date Source 16.4.1 Primary Sources 16.4.2 Secondary Sources 16.5 Data Cross Validation 16.6 Disclaimer
Publisher: DIResearch
Related Reports
- Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)
- Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)
- Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035
Why Market Study Report?
- Best Price for Reports
- Large Report Database
- Easily Customize Reports
- 24/7 Email & Phone Support